279 related articles for article (PubMed ID: 24487099)
1. Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system.
van Helden J; Grangeot-Keros L; Vauloup-Fellous C; Vleminckx R; Masset F; Revello MG
J Virol Methods; 2014 Apr; 199():108-15. PubMed ID: 24487099
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
[TBL] [Abstract][Full Text] [Related]
4. Performance of Elecsys toxo IgG and IgM immunoassays.
Van Helden J
Clin Lab; 2009; 55(7-8):267-73. PubMed ID: 19894405
[TBL] [Abstract][Full Text] [Related]
5. Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards Rubella virus.
Portella G; Galli C;
J Clin Virol; 2010 Oct; 49(2):105-10. PubMed ID: 20728403
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the new ARCHITECT Rubella IgM assay.
Eichler R; Prostko J; Fischer C; Hausmann M; Christ H
J Clin Virol; 2007 Jul; 39(3):182-7. PubMed ID: 17543576
[TBL] [Abstract][Full Text] [Related]
7. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
Hofmann J; Liebert UG
J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.
Medici MC; Martinelli M; Albonetti V; Chezzi C; Dettori G
J Clin Microbiol; 2008 May; 46(5):1847-9. PubMed ID: 18367579
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status.
Enders M; Bartelt U; Knotek F; Bunn K; Strobel S; Dietz K; Enders G
Clin Vaccine Immunol; 2013 Mar; 20(3):420-6. PubMed ID: 23345585
[TBL] [Abstract][Full Text] [Related]
11. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.
Binnicker MJ; Jespersen DJ; Harring JA
Clin Vaccine Immunol; 2010 Nov; 17(11):1734-8. PubMed ID: 20861325
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two automated immunoassays for the determination of Puumalavirus IgM and IgG.
Muyldermans A; Lagrou K; Patteet S; Van Esbroeck M; Van Ranst M; Saegeman V
J Clin Virol; 2014 Jun; 60(2):165-7. PubMed ID: 24713176
[TBL] [Abstract][Full Text] [Related]
13. Comparison of automated chemiluminescence immunoassays with capture enzyme immunoassays for the detection of measles and mumps IgM antibodies in serum.
Haywood B; Patel M; Hurday S; Copping R; Webster D; Irish D; Haque T
J Virol Methods; 2014 Feb; 196():15-7. PubMed ID: 24183918
[TBL] [Abstract][Full Text] [Related]
14. Digital microfluidic platform for the detection of rubella infection and immunity: a proof of concept.
Ng AH; Lee M; Choi K; Fischer AT; Robinson JM; Wheeler AR
Clin Chem; 2015 Feb; 61(2):420-9. PubMed ID: 25512641
[TBL] [Abstract][Full Text] [Related]
15. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
Carlier P; Harika N; Bailly R; Vranken G
J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
Liermann K; Schäfler A; Henke A; Sauerbrei A
J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
[TBL] [Abstract][Full Text] [Related]
17. Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection.
Abbott GG; Safford JW; MacDonald RG; Craine MC; Applegren RR
J Virol Methods; 1990 Feb; 27(2):227-39. PubMed ID: 2318930
[TBL] [Abstract][Full Text] [Related]
18. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of tests for detection of parvovirus B19 IgG and IgM.
de Ory F; Minguito T; Echevarría JE; Del Mar Mosquera M; Fuertes A
APMIS; 2014 Mar; 122(3):223-9. PubMed ID: 23763266
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of the Elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.
Esteban JI; van Helden J; Alborino F; Bürgisser P; Cellerai C; Pantaleo G; Eiras A; Rodriguez MI; Ghisetti V; Gleich M; Imdahl R; Kaiser C; Möller P; Wetlitzky O; Segovia M; Schennach H; Mühlbacher A
J Med Virol; 2013 Aug; 85(8):1362-8. PubMed ID: 23765774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
